
Tiba Aynechi
General Partner
Tiba joins Norwest as a biotech investor with over 20 years of research and investment experience. Previously with Novo Holdings, she deployed $280 million across private biotech and healthcare companies. Began her career in M&A, licensing, and financing in the biotech and pharma sectors.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
India
USA
Latin America
Investment ranges
Not found
Focus areas
Enterprise
E-commerce
Fintech
AI
Education
Proptech
Future of Work
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.